Back

Shortening dual antiplatelet therapy duration: how, when and why?

28 August 2023 (11:45 - 12:00)
Organised by: Logo
Congress Presentation Part of: Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more Interventional Cardiology ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Valeria Paradies

Maasstad Hospital, Rotterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Assessing bleeding and ischaemic risk: which tools and for whom?
Professor M. Valgimigli (Lugano, CH)
Slides Video
Presentation thumbnail
Prolonging and escalating dual antiplatelet therapy duration: how, when and why?
Professor D. Cohen (New York City, US)
Slides Video
Presentation thumbnail
De-escalating dual antiplatelet therapy after acute coronary syndrome
Associate Professor J. Siller-Matula (Vienna, AT)
Slides Video

Access the full session

Session thumbnail
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 11:45 CET
You may be interested in
thumbnail
Congress Presentation
Should 12 months of dual antiplatelet therapy still be the default recommendation after primary PCI?
thumbnail
Congress Presentation
Discussant review - DUAL-ACS
thumbnail
Congress Presentation
Antithrombotic therapy: walking the tightrope between the risk of ischaemia vs. the risk of bleeding

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources